| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.02 | 0.8 |